Moderna: Next-gen COVID shot prompts strong immune response

Moderna said today its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying risk condition.

See the original article at: Honolulu Star-Advertiser